OCGN · ISSUER CIK 1372299
Ocugen, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Ocugen, Inc. insiders reported $0.00 of open-market purchases and $1.1M of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.1MInsider selling
−$1.1MNet open-market
Oct 13, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 202621:07 | Oct 9, 2026 | OCGN | Chief Executive Officer, Director | S · Sell10b5-1 | $0.95 | −525,991 | 4,018,470 | -12% | −$500K | ||
| Sep 11, 202621:13 | Sep 9, 2026 | OCGN | Chief Executive Officer, Director | S · Sell10b5-1 | $1.12 | −525,991 | 4,487,197 | -10% | −$589K |